Delivery Order SPE2DB22D1106-SPE2DB25FEVL8
Award Date
6/27/25
Potential Completion Date
6/30/25
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,790.56 firm fixed-price delivery order is for the supply of 100 capsules of the prescription medication Lisdexamfetamine 50 mg. The contract has an ultimate completion date of April 30, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,355.37 firm fixed-price delivery order is for the supply of 100 capsules of the prescription medication Lisdexamfetamine 60 mg. The contract has an ultimate completion date of May 12, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,140.36 firm fixed-price delivery order is for the supply of 100 capsules of 10 mg lisdexamfetamine, a prescription medication. The contract has an ultimate completion date of June 4, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,568,185,890 units of the medication lisdexamfetamine 50 mg capsule in 100-count packages. The $2,584.29 firm fixed-price delivery order has a completion date of May 9, 2025 and is not a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,444.25 delivery order contract is for the supply of Lisdexamfetamine 20 mg capsules, a medication used to treat certain medical conditions. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 22, 2025. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of lisdexamfetamine 70 mg capsules in 100-count packages, with a ceiling value of $2,157.67 and a performance period ending on June 27, 2025. This award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor,...
This federal contract award, valued at $1,610.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,567,936,569 units of the prescription medication lisdexamfetamine 10 mg capsules. The contract has an ultimate completion date of April 17, 2025 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award is for the delivery of Lisdexamfetamine 20 mg capsules in quantities of 100s. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,120.46 and is a firm fixed price delivery order with a period of performance through February 6, 2025. The contract is not set aside for any...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Lisdexamfetamine 60 mg capsules in 100-count packages. The contract has a firm fixed price of $7,408.93 and a completion date of June 11, 2025. This contract award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of 100 units of the prescription drug Lisdexamfetamine 60 mg capsules, with a total ceiling value of $1,391.50. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corporation holds a significant Indefinite Delivery...